- Home
- RPID vs CLGN Comparison
RPID vs CLGN Comparison
Compare RPID & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPID
- CLGN
- Stock Information
- Founded
- RPID 2006
- CLGN 2004
- Country
- RPID United States
- CLGN Israel
- Employees
- RPID N/A
- CLGN N/A
- Industry
- RPID Medical Specialities
- CLGN Industrial Specialties
- Sector
- RPID Health Care
- CLGN Health Care
- Exchange
- RPID Nasdaq
- CLGN Nasdaq
- Market Cap
- RPID 43.5M
- CLGN 46.2M
- IPO Year
- RPID 2021
- CLGN N/A
- Fundamental
- Price
- RPID $3.21
- CLGN $3.47
- Analyst Decision
- RPID Buy
- CLGN Strong Buy
- Analyst Count
- RPID 1
- CLGN 2
- Target Price
- RPID $8.00
- CLGN $12.50
- AVG Volume (30 Days)
- RPID 583.3K
- CLGN 5.1K
- Earning Date
- RPID 02-28-2025
- CLGN 04-03-2025
- Dividend Yield
- RPID N/A
- CLGN N/A
- EPS Growth
- RPID N/A
- CLGN N/A
- EPS
- RPID N/A
- CLGN N/A
- Revenue
- RPID $26,170,000.00
- CLGN $650,000.00
- Revenue This Year
- RPID $25.32
- CLGN N/A
- Revenue Next Year
- RPID $18.92
- CLGN $692.59
- P/E Ratio
- RPID N/A
- CLGN N/A
- Revenue Growth
- RPID 27.31
- CLGN N/A
- 52 Week Low
- RPID $0.58
- CLGN $3.24
- 52 Week High
- RPID $4.04
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- RPID 62.15
- CLGN 36.66
- Support Level
- RPID $3.38
- CLGN $3.52
- Resistance Level
- RPID $4.04
- CLGN $3.70
- Average True Range (ATR)
- RPID 0.51
- CLGN 0.16
- MACD
- RPID 0.04
- CLGN -0.02
- Stochastic Oscillator
- RPID 64.11
- CLGN 3.64
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.